RetinAI is a technology company that specializes in creating a data management platform integrated with AI modules, designed to improve understanding of patients' diseases and outcomes through enhanced insights and knowledge.

RetinAI

Ophtalmo offers products and services in the field of ophthalmology, including surgical supplies, consumables, and medical devices. The company self-described as a trusted partner in ophthalmology.

Ophtalmo

Retina Clinic specializes in the treatment of retinal and vitreous diseases.

Retina Clinic

Beverly Hills Institute of Ophthalmology provides ophthalmology services including LASIK surgery, cataract surgery, and comprehensive eye care. The institute is described as having advanced technology and a team of experienced ophthalmologists.

Beverly Hills Institute of Ophthalmology

RetinAI is a Swiss & US-based software company improving and supporting R&D of first-in-human drug candidates, supercharging management and oversight of clinical trials and enabling the research needed to elevate the quality of care on patients with eye diseases. 

We achieve this goal by building tools to collect, analyze and to organize health data. Our fundamental belief is that in the future every patient will use drugs alongside a digital application that will enable them and their physicians to better assess the right drug, in the right amount and the right frequency for patients.



Eurostars

Venture Kick

Matterwave Ventures

btov Partners

Verve Ventures

Retinai

BSI has certified our platform RetinAI Discovery and 3 of our #AI models under the Medical Devices Regulation EU 2017/745! This certification underscores our commitment to excellence and compliance with the highest industry standards.

What this means: 
👉 Our quality management system met the rigorous requirements of the EU Medical Device Regulation (EU) 2017/745, ensuring top-tier safety and effectiveness.
👉 Our advanced ophthalmology assessment and diagnostic support technologies, including RetinAI's AI models for Macula Biomarkers, Layer Segmentation and Fluid Segmentation models, have been validated and recognized to meet a healthcare need.
👉 With this certification, we strengthen our position as a trusted pioneer in the AI healthcare technology space.

This milestone is a testament to our team's dedication and the robust quality systems we have in place. Thank you to our team, partners, and clients for their unwavering support.

Together, we are shaping the future of eye care!

For more information, read the press release 👉 https://lnkd.in/ecsjmHQW 

#MDRCertification #AIinHealthcare #Innovation #QualityAssurance #HealthcareTech Ikerian

On Monday, some of our Retinauts gathered for a fantastic barbecue party under the sunny skies of Switzerland's beautiful capital 😎

From exciting games to the Rodelbahn ride, the day was filled with fun and laughter. Our team showed that work and play can blend perfectly!

A big shoutout to our Swiss-based team for organizing such a memorable event. We can't wait for the next adventure!

#TeamBuilding #Retinauts #SwissAdventures #WorkHardPlayHard #CompanyCulture #BernFun

Only 1 week left! Meet Aunia Grogan, our VP Business Development at the 2nd Annual Retinal Imaging Biomarkers & Endpoints Summit in Boston from June 25 to 27.

Aunia looks forward to joining this exciting forum and connecting with leading retinal experts like you!

Schedule your meeting with Aunia to get an overview of our solutions 👉 https://lnkd.in/e5U7kk2Y

See you in Boston!

We're excited to announce that Carlos Ciller, our co-founder and CEO will be a panelist today at the Swiss Medtech Day!

Join the session "The Promise of AI and Large Language Models (LLM) to Transform Healthcare" at 11:30 AM and 2:00 PM.

In this session, we'll explore how AI and LLM are revolutionizing medical device design and the broader healthcare industry. 

Discover the potential and challenges of integrating AI into medical products, from improved diagnostic and predictive analytics to the complexities of regulatory compliance and data privacy.

We look forward to engaging in meaningful discussions about the future of AI in healthcare. If you're attending the event, don't miss this insightful session!

Learn more about the event: https://lnkd.in/e2iscuDb

#SwissMedtechDay #AIinHealthcare #MedicalInnovation #HealthcareTechnology #AIandLLM #RetinAI

We recently sponsored a CPD-registered seminar led by the renowned Prof. Paulo Eduardo Stanga at The Retina Clinic London. This event focused on the state-of-the-art Diagnostic Technologies and Techniques in Retina, and on how AI is transforming clinical workflows in Ophthalmology!

Key highlights of the event:

✅ AI can reshape clinical practice and support diagnostics
✅ AI is integral to streamlining workflows and saving time
✅ Case studies highlighted the potential of AI to revolutionize treatment and patient care

We believe in innovation and are dedicated to supporting those who strive to make a difference.

AI is a powerful tool for healthcare professionals, enabling them to tackle challenging cases more effectively.

If you want to have a demo or get to know our solutions better, visit our website 👉 https://www.retinai.com/

#AIinHealthcare #Ophthalmology #Innovation #ClinicalWorkflows #HealthcareRevolution #FutureOfDiagnostics #MedicalInnovation #AI #HealthcareProfessionals #Eyecare


In a few weeks, we will be participating in the Retinal Imaging Biomarkers & Endpoints Summit in Boston!

From June 25 to 27, you can meet Aunia Grogan at the Hilton Boston Back Bay who will walk you through our data and AI solutions, showing you how RetinAI Discovery can enhance and accelerate imaging analysis for biomarkers, and optimize clinical trial workflows.

If you are attending the Summit, schedule a meeting with Aunia in advance 👉 https://lnkd.in/eF7CXeB3

#ophthalmology #eyecare #research #clinicalresearch #healthcare #digitalhealthcare #artificialintelligence #machinelearning

Metric
Company Name	RetinAI	Ophtalmo	Retina Clinic	Beverly Hills Institute of Ophthalmology
Symbol
MSH ID	COM:RETINAI	BE:OPHTALMOSERVICE	BR:COM:RETINA	COM:90210EYES
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare Technology	Medical Equipment & Supplies	Medical Services	Medical Services
Country	CH	BE	BR	US
Stage	Series B
Employee Count	38
Website	retinai.com	ophtalmoservice.be	retina.com.br	90210eyes.com
LinkedIn	retinai		retina-clinic
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	9.75K
Web Traffic Growth	0.67
Valuation
Raised Capital	7.80M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:RETINAI

RetinAI

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue